Large Molecule Injectable Drugs
Large Molecule Injectable Drugs market is segmented by players, region (country), by Type and by ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gastroparesis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Drug Treatment 1.2.3 Surgical Treatment 1.3 Market by Application 1.3.1 Global Gastroparesis Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Ambulatory Surgical Center 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gastroparesis Treatment Market Perspective (2017-2028) 2.2 Gastroparesis Treatment Growth Trends by Region 2.2.1 Gastroparesis Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Gastroparesis Treatment Historic Market Size by Region (2017-2022) 2.2.3 Gastroparesis Treatment Forecasted Market Size by Region (2023-2028) 2.3 Gastroparesis Treatment Market Dynamics 2.3.1 Gastroparesis Treatment Industry Trends 2.3.2 Gastroparesis Treatment Market Drivers 2.3.3 Gastroparesis Treatment Market Challenges 2.3.4 Gastroparesis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gastroparesis Treatment Players by Revenue 3.1.1 Global Top Gastroparesis Treatment Players by Revenue (2017-2022) 3.1.2 Global Gastroparesis Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Gastroparesis Treatment Revenue 3.4 Global Gastroparesis Treatment Market Concentration Ratio 3.4.1 Global Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gastroparesis Treatment Revenue in 2021 3.5 Gastroparesis Treatment Key Players Head office and Area Served 3.6 Key Players Gastroparesis Treatment Product Solution and Service 3.7 Date of Enter into Gastroparesis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gastroparesis Treatment Breakdown Data by Type 4.1 Global Gastroparesis Treatment Historic Market Size by Type (2017-2022) 4.2 Global Gastroparesis Treatment Forecasted Market Size by Type (2023-2028) 5 Gastroparesis Treatment Breakdown Data by Application 5.1 Global Gastroparesis Treatment Historic Market Size by Application (2017-2022) 5.2 Global Gastroparesis Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Gastroparesis Treatment Market Size (2017-2028) 6.2 North America Gastroparesis Treatment Market Size by Country (2017-2022) 6.3 North America Gastroparesis Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Gastroparesis Treatment Market Size (2017-2028) 7.2 Europe Gastroparesis Treatment Market Size by Country (2017-2022) 7.3 Europe Gastroparesis Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Gastroparesis Treatment Market Size (2017-2028) 8.2 Asia-Pacific Gastroparesis Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Gastroparesis Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Gastroparesis Treatment Market Size (2017-2028) 9.2 Latin America Gastroparesis Treatment Market Size by Country (2017-2022) 9.3 Latin America Gastroparesis Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gastroparesis Treatment Market Size (2017-2028) 10.2 Middle East & Africa Gastroparesis Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Gastroparesis Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Medtronic 11.1.1 Medtronic Company Detail 11.1.2 Medtronic Business Overview 11.1.3 Medtronic Gastroparesis Treatment Introduction 11.1.4 Medtronic Revenue in Gastroparesis Treatment Business (2017-2022) 11.1.5 Medtronic Recent Development 11.2 Abbott 11.2.1 Abbott Company Detail 11.2.2 Abbott Business Overview 11.2.3 Abbott Gastroparesis Treatment Introduction 11.2.4 Abbott Revenue in Gastroparesis Treatment Business (2017-2022) 11.2.5 Abbott Recent Development 11.3 Bausch Health 11.3.1 Bausch Health Company Detail 11.3.2 Bausch Health Business Overview 11.3.3 Bausch Health Gastroparesis Treatment Introduction 11.3.4 Bausch Health Revenue in Gastroparesis Treatment Business (2017-2022) 11.3.5 Bausch Health Recent Development 11.4 Boston Scientific 11.4.1 Boston Scientific Company Detail 11.4.2 Boston Scientific Business Overview 11.4.3 Boston Scientific Gastroparesis Treatment Introduction 11.4.4 Boston Scientific Revenue in Gastroparesis Treatment Business (2017-2022) 11.4.5 Boston Scientific Recent Development 11.5 C.R. Bard 11.5.1 C.R. Bard Company Detail 11.5.2 C.R. Bard Business Overview 11.5.3 C.R. Bard Gastroparesis Treatment Introduction 11.5.4 C.R. Bard Revenue in Gastroparesis Treatment Business (2017-2022) 11.5.5 C.R. Bard Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Detail 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Gastroparesis Treatment Introduction 11.6.4 Johnson & Johnson Revenue in Gastroparesis Treatment Business (2017-2022) 11.6.5 Johnson & Johnson Recent Development 11.7 Cardinal Health 11.7.1 Cardinal Health Company Detail 11.7.2 Cardinal Health Business Overview 11.7.3 Cardinal Health Gastroparesis Treatment Introduction 11.7.4 Cardinal Health Revenue in Gastroparesis Treatment Business (2017-2022) 11.7.5 Cardinal Health Recent Development 11.8 Evoke Pharma 11.8.1 Evoke Pharma Company Detail 11.8.2 Evoke Pharma Business Overview 11.8.3 Evoke Pharma Gastroparesis Treatment Introduction 11.8.4 Evoke Pharma Revenue in Gastroparesis Treatment Business (2017-2022) 11.8.5 Evoke Pharma Recent Development 11.9 Rhythm Pharmaceuticals 11.9.1 Rhythm Pharmaceuticals Company Detail 11.9.2 Rhythm Pharmaceuticals Business Overview 11.9.3 Rhythm Pharmaceuticals Gastroparesis Treatment Introduction 11.9.4 Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2017-2022) 11.9.5 Rhythm Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Gastroparesis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Drug Treatment Table 3. Key Players of Surgical Treatment Table 4. Global Gastroparesis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Gastroparesis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Gastroparesis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Gastroparesis Treatment Market Share by Region (2017-2022) Table 8. Global Gastroparesis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Gastroparesis Treatment Market Share by Region (2023-2028) Table 10. Gastroparesis Treatment Market Trends Table 11. Gastroparesis Treatment Market Drivers Table 12. Gastroparesis Treatment Market Challenges Table 13. Gastroparesis Treatment Market Restraints Table 14. Global Gastroparesis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Gastroparesis Treatment Market Share by Players (2017-2022) Table 16. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Treatment as of 2021) Table 17. Ranking of Global Top Gastroparesis Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Gastroparesis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Gastroparesis Treatment Product Solution and Service Table 21. Date of Enter into Gastroparesis Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gastroparesis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Gastroparesis Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Gastroparesis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Gastroparesis Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Gastroparesis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Gastroparesis Treatment Revenue Market Share by Application (2017-2022) Table 29. Global Gastroparesis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Gastroparesis Treatment Revenue Market Share by Application (2023-2028) Table 31. North America Gastroparesis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Gastroparesis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Gastroparesis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Gastroparesis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Gastroparesis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Gastroparesis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Gastroparesis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Gastroparesis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Gastroparesis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Gastroparesis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Medtronic Company Detail Table 42. Medtronic Business Overview Table 43. Medtronic Gastroparesis Treatment Product Table 44. Medtronic Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 45. Medtronic Recent Development Table 46. Abbott Company Detail Table 47. Abbott Business Overview Table 48. Abbott Gastroparesis Treatment Product Table 49. Abbott Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 50. Abbott Recent Development Table 51. Bausch Health Company Detail Table 52. Bausch Health Business Overview Table 53. Bausch Health Gastroparesis Treatment Product Table 54. Bausch Health Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 55. Bausch Health Recent Development Table 56. Boston Scientific Company Detail Table 57. Boston Scientific Business Overview Table 58. Boston Scientific Gastroparesis Treatment Product Table 59. Boston Scientific Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 60. Boston Scientific Recent Development Table 61. C.R. Bard Company Detail Table 62. C.R. Bard Business Overview Table 63. C.R. Bard Gastroparesis Treatment Product Table 64. C.R. Bard Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 65. C.R. Bard Recent Development Table 66. Johnson & Johnson Company Detail Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Gastroparesis Treatment Product Table 69. Johnson & Johnson Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 70. Johnson & Johnson Recent Development Table 71. Cardinal Health Company Detail Table 72. Cardinal Health Business Overview Table 73. Cardinal Health Gastroparesis Treatment Product Table 74. Cardinal Health Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 75. Cardinal Health Recent Development Table 76. Evoke Pharma Company Detail Table 77. Evoke Pharma Business Overview Table 78. Evoke Pharma Gastroparesis Treatment Product Table 79. Evoke Pharma Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 80. Evoke Pharma Recent Development Table 81. Rhythm Pharmaceuticals Company Detail Table 82. Rhythm Pharmaceuticals Business Overview Table 83. Rhythm Pharmaceuticals Gastroparesis Treatment Product Table 84. Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2017-2022) & (US$ Million) Table 85. Rhythm Pharmaceuticals Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastroparesis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Drug Treatment Features Figure 3. Surgical Treatment Features Figure 4. Global Gastroparesis Treatment Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Ambulatory Surgical Center Case Studies Figure 7. Others Case Studies Figure 8. Gastroparesis Treatment Report Years Considered Figure 9. Global Gastroparesis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Gastroparesis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Gastroparesis Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global Gastroparesis Treatment Market Share by Players in 2021 Figure 13. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Gastroparesis Treatment Revenue in 2021 Figure 15. North America Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Gastroparesis Treatment Market Share by Country (2017-2028) Figure 17. United States Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Gastroparesis Treatment Market Share by Country (2017-2028) Figure 21. Germany Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Gastroparesis Treatment Market Share by Region (2017-2028) Figure 29. China Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Gastroparesis Treatment Market Share by Country (2017-2028) Figure 37. Mexico Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Gastroparesis Treatment Market Share by Country (2017-2028) Figure 41. Turkey Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Gastroparesis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Medtronic Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 44. Abbott Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 45. Bausch Health Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 46. Boston Scientific Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 47. C.R. Bard Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 48. Johnson & Johnson Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 49. Cardinal Health Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 50. Evoke Pharma Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 51. Rhythm Pharmaceuticals Revenue Growth Rate in Gastroparesis Treatment Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed
Medtronic Abbott Bausch Health Boston Scientific C.R. Bard Johnson & Johnson Cardinal Health Evoke Pharma Rhythm Pharmaceuticals
Large Molecule Injectable Drugs market is segmented by players, region (country), by Type and by ... Read More
Dysplasia Epiphysealis Hemimelica Treatment market is segmented by players, region (country), by ... Read More
Syphilis Diagnosis market is segmented by players, region (country), by Type and by Application. ... Read More
Primitive Neuroectodermal Tumors (PNET) Treatment market is segmented by players, region (country ... Read More